Navigation Links
Cellectar Expands Clinical Management Team
Date:10/3/2007

- Appoints Director, Clinical Operations and Manager, Medical Affairs -

MADISON, Wis., Oct. 3 /PRNewswire/ -- Cellectar LLC, (Cellectar), a privately-held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced the appointment of Ernest Allen as Director, Clinical Operations and LisaAnn Trembath as Manager of Medical Affairs. These appointments reflect the advancement of the company's lead product, CLR1404, toward clinical trials.

Prior to joining Cellectar, Mr. Allen spent over 20 years in progressively senior positions in clinical operations for pharmaceutical companies including Alcon, Amgen, Parke-Davis and Origin Pharmaceuticals, Inc., a U.K.-based Clinical Research Organization (CRO), where he served as Senior Clinical Manager. Most recently, he was Clinical Manager for Tapestry Pharmaceuticals, Inc., a cancer treatment pharmaceutical company located in Boulder, CO.

Ms. Trembath brings 21 years of experience as a nuclear medicine technologist specializing in medical imaging, including 10 years of clinical trials research experience and nine years in the radiopharmaceuticals industry. Immediately prior to joining Cellectar, Ms. Trembath was a Senior Clinical Affairs Specialist in the Medical Affairs Division at Bristol-Myers Squibb Medical Imaging, where she developed tools and educational programs for partner clinicians and field personnel. Prior to her position at BMS, she coordinated clinical trials research at the Medical College of Wisconsin and project management at Affiliated Research Centers.

Bill Clarke, M.D., Cellectar's President and CEO, commented, "As we advance our lead product candidate, CLR1404, toward clinical trials, Ernest and LisaAnn bring the necessary clinical development skills needed for our progression. These highly experienced individuals are excellent additions to our team."

CLR1404 is currently in preclinical development and the co
'/>"/>

SOURCE Cellectar LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCa...unced results for its first quarter ended Septembe... per diluted share, on revenues of $3,263,000. Th...per diluted share, on revenues of $3,168,000 for t... the first quarter results, Biotel President and C...
(Date:11/20/2009)..., , PRINCETON, N.J., Nov. 20 /PRNewswire-... SNGX) (Soligenix or the Company), formerly known ... company, announced today that it has formed a con...nce RiVax(TM) and other rapidly acting vaccines. S...tional Institute of Allergy and Infectious Disease...
(Date:11/19/2009)..., , TAINAN, Taiwan, Nov. 19 /PRNewswi...of active pharmaceutical ingredients (APIs), annou...ent Compound Safety Certification from,SafeBridge(...inoPharm,s,competency and proficiency in the safe ...ts (APIs), and applies to specific laboratories an...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 1Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 2Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 3Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 4Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 5Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 6Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle Aged People at Genetic Risk for Alzheimers Disease 4728 7 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 1 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 2 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 3Narconon of Georgia Saves Lives of Orphaned Children in Honduras 51834 1Narconon of Georgia Saves Lives of Orphaned Children in Honduras 51834 2
(Date:11/22/2009)...iday season is filled with get-togethers with fami...can also be stressful and tiring at times. Experts...nd high fat foods -- factors that can, over time, ...nal Foundation for Cancer Research has developed a...appier, more healthful holiday season, and can, ov...
(Date:11/22/2009)...Newswire-USNewswire/ -- Congressman Chaka Fattah (...ed States Senate,s vote tonight to proceed to deba...enators Arlen Specter and Bob Casey deserve the th...casting stand-up, critical votes in the Senate ton...le Health Care Reform legislation to full debate. ...
(Date:11/21/2009)...PRNewswire-USNewswire/ -- DNC Chairman Tim Kaine i...ed to begin full debate of health insurance reform...m/cgi-bin/prnh/20080519/DNCLOGO ) ,, "Today, ...to enacting health insurance reform. By clearing t...e an opportunity to debate the health reform bill ...
(Date:11/21/2009)...Newswire/ -- Milvia Lopez, by her attorney MICHAEL... suit, in Supreme Court, New York County, bearing ...ile Ms. Lopez underwent a routine transesophageal ..., doctors used an HIV infected scope exposing her ... hours after being discharged from the procedure a...
(Date:11/21/2009)...s Key Provisions of Legislation, Continues Push fo...S, Ill., Nov. 21 With...dmark Affordable Health Care for America Act (H.R....gislation forward, Congress has taken decisive ste... Today, AARP hosted an educational forum to discus...
Breaking Medicine News(10 mins):Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2
...nsafe injection in India is the cause of serious h...e administered in India and the results show that ...-sterile or unsafe and pose serious health hazards...y time and the amount of people from developing co...
...conducted to evaluate the effectiveness of environ...sted that home based intervention program would be...ldren// with the condition. The study was conducte...symptoms and included dust mites, cockroaches, pet...
... risk factors are known to play a role in the deve...AD). However, little is known about the effect of ...ctors on the development of dementia//. Recent... mass index and clustering of vascular risk factor...
... dysfunction (ED) is the inability of a man to ach...xual needs or the needs of his partner. Most men e...ally by age 40, and are not psychologically affect...he October 18 issue of the Journal of the American...
...V vaccine is being jointly developed by Vical Phar...NIH). The new HIV vaccine was developed by the sci...g the Vical Biotechs DNA delivery technology to in...h Vical has agreed to grant Merck to use its gene ...
...atory medical unit has been set up in Pakistani Ka...victims of the devastating earthquake. The ho...prises of a total of 52 German doctors and other p...ility has proved to be a boon to the victims of th...
Other Medicine News:Health News:Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India 2Health News:Erectile dysfunction: an early warning sign of clinically silent coronary artery disease? 2
... to Bottled Water, The Simplicity personal water s...s that currently use bottled water. In addition to...ottled water, your laboratory applications may be ...ntainers and cause water quality to degrade over t...
arium 611 Ultrapure Water Systems
...min of Type I ultrapure water, , Ultrapure Water Q...ned to provide the "final polish" to water which h...n or deionization. Super-Q Plus systems consistent...ype I ASTM/CAP/NCCLS specifications.,The Super-Q P...
...ratory Needs, Synergy systems produce ultrapure wa...o 1.2 L/min to meet the basic needs of scientific ...a dual-wavelength UV lamp (185 nm and 254 nm) to p...ts (< 5 ppb TOC when fed by Elix water). Water qua...
Medicine Products: